This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: International Stem Cell Corporation. Active years: 2012-2015.
Company Filing History:
Years Active: 2012-2015
Title: Larisa Agapova: Innovator in Stem Cell Research
Introduction
Larisa Agapova is a prominent inventor based in Vista, CA (US), known for her significant contributions to the field of stem cell research. With a total of 2 patents, she has made remarkable strides in developing methods for deriving differentiated cells from stem cells.
Latest Patents
Agapova's latest patents include innovative methods for generating definitive endoderm, mesoderm, or ectoderm cells. The first patent outlines a method that involves culturing embryonic stem cells, parthenogenetic cells, or induced pluripotent stem cells in the presence of a demethylation agent and a histone deacetylase inhibitor. Following this, the stem cells are cultured in the absence of these agents to produce definitive endoderm cells, mesoderm, or ectoderm cells. The second patent focuses specifically on deriving definitive endoderm cells from pluripotent parthenogenetic stem cells, utilizing a similar approach.
Career Highlights
Agapova is affiliated with International Stem Cell Corporation, where she applies her expertise in stem cell technology. Her work has been instrumental in advancing the understanding and application of stem cell differentiation.
Collaborations
Throughout her career, Agapova has collaborated with notable colleagues, including Nikolay Turovets and Andrey Semechkin, contributing to a dynamic research environment.
Conclusion
Larisa Agapova's innovative work in stem cell research exemplifies her commitment to advancing medical science. Her patents reflect her dedication to developing new methods that could have significant implications for regenerative medicine.